Atropine

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two…

Treating U.S. children with an investigational low-dose (0.01%) formulation of…

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily…

Nightly use of 0.05% atropine eyedrops in kids led to a significantly lower incidence of…